Reulay

Founded by leading psychiatrists, neuroscientists, and AI researchers, Reulay's mission is to increase the quality of life and longevity for 2 billion humans by creating effective, scalable, and affordable digital health therapeutics. Reulay's virtual therapeutic platform leverages machine learning across biometric, digital behavior, brain science, and epigenetic research to personalize evidence-based digital medicine that targets human biology for prevention and treatment. Reulay is advancing a broad pipeline of products across VR, AR, Mobile, & Web interventions to decrease stress and anxiety disorders, as well as associated chronic medical conditions such as cancer, stroke, heart disease & neurodegenerative diseases.